methionine has been researched along with isocarboxazid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kakimoto, Y; Kanazawa, A; Kaneko, Z; Sano, I; Tsujio, T | 1 |
| BALDESSARINI, RJ; KETY, SS; PARK, LC | 1 |
1 review(s) available for methionine and isocarboxazid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for methionine and isocarboxazid
| Article | Year |
|---|---|
Metabolic effects of methionine in schizophrenic patients pretreated with a monoamine oxidase inhibitor.
Topics: Adult; Amines; Catechols; Epinephrine; Female; Humans; Isocarboxazid; Methionine; Methylation; Middle Aged; Norepinephrine; Normetanephrine; Schizophrenia | 1967 |
METHIONINE EFFECTS ON CHRONIC SCHIZOPHRENICS: PATIENTS TREATED WITH MONOAMINE OXIDASE INHIBITORS.
Topics: Biomedical Research; Drug Synergism; Drug Therapy; Glycine; Iproniazid; Isocarboxazid; Mental Disorders; Methionine; Monoamine Oxidase Inhibitors; Placebos; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Toxicology | 1965 |